In addition, some studies demonstrated that mutant SPOP can stabilize programmed death ligand 1 (PD-L1) protein expression via proteasome-mediated degradation and improve PCa treatment outcome on programmed death 1 (PD-1) immune checkpoint inhibitors [102,103]. Here, SPOP is linked to posterior cortical atrophy.